Rahul Banerjee, Assistant Professor at the Fred Hutchinson Cancer Center and at the University of Washington, shared a post on X:
“Marvelously written guidelines in British Journal of Haematology about frail patients with myeloma.
E.g., gems in section below:
1. Down with dex after 2 cycles
2. Dara-Rd is preferred quad-ineligible regimen
3. But still consider quad in some of these patients!
E.g., REST trial and number 1 above.”
Title: Assessment and treatment of frail patients living with multiple myeloma. A guideline on behalf of the UK Myeloma Research Alliance Frailty Group
Authors: Sally Moore, Hannah Miller, Christopher Parrish, Frances Seymour, Laura Miller, Thea Chandler, Joanne Land, Indrani Karpha, Gillian Brearton, Shelagh Thompson, Laura Clayton, John Jones, Annabel McMillan, Orla McCourt, Charlotte Pawlyn, Hira Mian, Gordon Cook
Read The Full Article at British Journal of Haematology.
More posts featuring Rahul Banerjee on OncoDaily.